Media Coverage - Jiangxi Fushine Pharmaceutical Co., Ltd.

Home · News & Insights · Media Coverage ·

2024-09-24

Synthetic Biology Becomes a Major Growth Track—Fushine Pharmaceutical Builds a New Engine for Expansion

On September 15, China’s State Council released guidelines on developing a more diversified food-supply system under the “Big Food Concept,” encouraging the use of broader biological resources and the development of new food technologies.

2024-05-19

"Financial Analysis" Microbial protein track emerges, Fushine Pharmaceuticals accelerates the industrialization of 10,000 tons of microbial protein

2025-01-26

Fushine Pharmaceuticals' Weiran Protein Receives Self-GRAS Certification and Officially Enters the U.S. Synthetic Biology Market
2024-10-09

Fushine Pharmaceuticals signed a technology transfer cooperation agreement with Jiangxi Normal University to upgrade its processes to achieve cost reduction and efficiency improvement.
2024-09-24

Synthetic Biology Becomes a Major Growth Track—Fushine Pharmaceutical Builds a New Engine for Expansion
2024-05-29

Research and development of microbial proteins using glucose, water, etc. as raw materials
2024-05-19

"Financial Analysis" Microbial protein track emerges, Fushine Pharmaceuticals accelerates the industrialization of 10,000 tons of microbial protein
2024-04-30

The concept of synthetic biology continues to gain momentum. Fushine Pharmaceuticals' microbial protein industrialization has moved from 1,000 tons to 10,000 tons.